Home

Κατακτώ τηλεόραση Επιμελής breast cancer information core bic Προμήθεια μπαρμπεκιου περιεχόμενο

Identification of the most common BRCA alterations through analysis of  germline mutation databases: Is droplet digital PCR an additional strategy  for the assessment of such alterations in breast and ovarian cancer  families?
Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families?

Germline sequence variants contributing to cancer susceptibility in South  African breast cancer patients of African ancestry | Scientific Reports
Germline sequence variants contributing to cancer susceptibility in South African breast cancer patients of African ancestry | Scientific Reports

Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations  in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or  ovarian cancer individuals | Breast Cancer Research | Full Text
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals | Breast Cancer Research | Full Text

🌸 Join BIC Services in Honouring Breast Cancer Awareness Month! | BIC  Services posted on the topic | LinkedIn
🌸 Join BIC Services in Honouring Breast Cancer Awareness Month! | BIC Services posted on the topic | LinkedIn

Links
Links

Genes | Free Full-Text | Imprecise Medicine: BRCA2 Variants of Uncertain  Significance (VUS), the Challenges and Benefits to Integrate a Functional  Assay Workflow with Clinical Decision Rules
Genes | Free Full-Text | Imprecise Medicine: BRCA2 Variants of Uncertain Significance (VUS), the Challenges and Benefits to Integrate a Functional Assay Workflow with Clinical Decision Rules

Outcome of conservatively managed early-onset breast cancer by BRCA1/2  status - The Lancet
Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status - The Lancet

KoreaMed Synapse
KoreaMed Synapse

Abbreviation: BIC, Breast Cancer Information Core database. a GenBank... |  Download Scientific Diagram
Abbreviation: BIC, Breast Cancer Information Core database. a GenBank... | Download Scientific Diagram

High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast  cancer patients - Fackenthal - 2012 - International Journal of Cancer -  Wiley Online Library
High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients - Fackenthal - 2012 - International Journal of Cancer - Wiley Online Library

Genes | Free Full-Text | Differences in Ovarian and Other Cancers Risks by  Population and BRCA Mutation Location
Genes | Free Full-Text | Differences in Ovarian and Other Cancers Risks by Population and BRCA Mutation Location

Genetics, tumor features and treatment response of breast cancer in Latinas  | Breast Cancer Management
Genetics, tumor features and treatment response of breast cancer in Latinas | Breast Cancer Management

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1  and BRCA2 | PLOS Genetics
BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2 | PLOS Genetics

Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations  in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or  ovarian cancer individuals | Breast Cancer Research | Full Text
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals | Breast Cancer Research | Full Text

Frontiers | Assessing the pathogenicity of BRCA1/2 variants of unknown  significance: Relevance and challenges for breast cancer precision medicine
Frontiers | Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine

Table 2 from Suggestion of BRCA1 c.5339T>C (p.L1780P) variant confer  from 'unknown significance' to 'Likely pathogenic' based on clinical  evidence in Korea. | Semantic Scholar
Table 2 from Suggestion of BRCA1 c.5339T>C (p.L1780P) variant confer from 'unknown significance' to 'Likely pathogenic' based on clinical evidence in Korea. | Semantic Scholar

BRCA1/2 testing: therapeutic implications for breast cancer management |  British Journal of Cancer
BRCA1/2 testing: therapeutic implications for breast cancer management | British Journal of Cancer

Genes | Free Full-Text | Prevalence and Spectrum of BRCA Germline Variants  in Central Italian High Risk or Familial Breast/Ovarian Cancer Patients: A  Monocentric Study
Genes | Free Full-Text | Prevalence and Spectrum of BRCA Germline Variants in Central Italian High Risk or Familial Breast/Ovarian Cancer Patients: A Monocentric Study

The Breast Cancer Information Core: Database design, structure, and scope -  Szabo - 2000 - Human Mutation - Wiley Online Library
The Breast Cancer Information Core: Database design, structure, and scope - Szabo - 2000 - Human Mutation - Wiley Online Library

PDF) The Breast Cancer Information Core: Database design, structure, and  scope
PDF) The Breast Cancer Information Core: Database design, structure, and scope

Identification of BRCA1/2 Founder Mutations in Southern Chinese Breast  Cancer Patients Using Gene Sequencing and High Resolution DNA Melting  Analysis – topic of research paper in Biological sciences. Download  scholarly article PDF
Identification of BRCA1/2 Founder Mutations in Southern Chinese Breast Cancer Patients Using Gene Sequencing and High Resolution DNA Melting Analysis – topic of research paper in Biological sciences. Download scholarly article PDF

Diagnostics | Free Full-Text | Male Breast Cancer: Results of the  Application of Multigene Panel Testing to an Italian Cohort of Patients
Diagnostics | Free Full-Text | Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients

Cisplatin with veliparib or placebo in metastatic triple-negative breast  cancer and BRCA mutation-associated breast cancer (S1416): a randomised,  double-blind, placebo-controlled, phase 2 trial - The Lancet Oncology
Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Oncology

The Breast Information Core (BIC) Website Features. Overview and map of...  | Download Scientific Diagram
The Breast Information Core (BIC) Website Features. Overview and map of... | Download Scientific Diagram

Abbreviation: BIC, Breast Cancer Information Core database. a GenBank... |  Download Scientific Diagram
Abbreviation: BIC, Breast Cancer Information Core database. a GenBank... | Download Scientific Diagram

Spectrum and prevalence of BRCA1/2 germline mutations in Pakistani breast  cancer patients: results from a large comprehensive study | Hereditary  Cancer in Clinical Practice | Full Text
Spectrum and prevalence of BRCA1/2 germline mutations in Pakistani breast cancer patients: results from a large comprehensive study | Hereditary Cancer in Clinical Practice | Full Text